Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, PK, and target engagement of GSK3858279 in healthy participants with exploratory efficacy assessment in osteoarth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Conditions
• Osteoarthritis
• Pain

Drugs mentioned

• GSK3858279

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain, Inflammatory | Phase 1 | Status: COMPLETED | Results posted: 2024-03-22